To study the nature,mechanism and common drug class involved in possible drug-drug interactions in emergency medicine department patients admitted for at least two days in emergency department wards.
Phase 4
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2020/01/022913
- Lead Sponsor
- Kempegowda Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
1).Patients admitted to emergency medicine department for minimum 48 hours
2).Subjects receiving two or more drugs
3).Willingness of patients/legal representatives to give written informed consent
4).All patients admitted to emergency medicine department aged 18 years and above
Exclusion Criteria
1.Patient not willing to give informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To generate valid and useful DDIs data in Emergency Medicine departmentTimepoint: At the end of study-1year 6months
- Secondary Outcome Measures
Name Time Method To identify common drug class involved in drug-drug interactionsTimepoint: 1.5yrs